• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

知情同意政策的变化与卒中溶栓治疗的延误。

Changes in Informed Consent Policy and Treatment Delays in Stroke Thrombolysis.

机构信息

Department of Family Medicine and Community Health, Duke University School of Medicine, 2200 West Main Street, Office 624, 27705 Durham, NC, USA; Duke University School of Nursing, Durham, NC, USA.

Department of Neurology, National Neuroscience Institute, Singapore General Hospital, Singapore.

出版信息

J Stroke Cerebrovasc Dis. 2021 Mar;30(3):105551. doi: 10.1016/j.jstrokecerebrovasdis.2020.105551. Epub 2020 Dec 19.

DOI:10.1016/j.jstrokecerebrovasdis.2020.105551
PMID:33348248
Abstract

OBJECTIVES

The efficacy of thrombolytic therapy with tissue plasminogen activator (tPA) is highly time dependent. Although clinical guidelines do not recommend written informed consent as it may cause treatment delays, local policy can supersede and require it. From 2014 to 2017, three out of five public hospitals in Singapore changed from written to verbal consent at different time points. We aimed to examine the association of hospital policy changes regarding informed consent on door-to-needle (DTN) times.

MATERIALS AND METHODS

Using data from the Singapore Stroke Registry and surveys of local practice, we analyzed data of 915 acute ischemic stroke patients treated with tPA within 3 hours in all public hospitals between July 2014 to Dec 2017. Patient-level DTN times before and after policy changes were examined while adjusting for clinical characteristics, within-hospital clustering, and trends over time.

RESULTS

Patient characteristics and stroke severity were similar before and after the policy changes. Overall, the median DTN times decreased from 68 to 53 minutes after the policy changes. After risk adjustment, changing from written to verbal informed consent was associated with a 5.6 minutes reduction (95% CI 1.1-10.0) in DTN times. After the policy changed, the percentage of patients with DTN ≤60 minutes and ≤45 minutes increased from 35.6% to 66.1% (adjusted OR 1.75; 95% CI 1.12-2.74) and 9.3% to 36.0% (adjusted OR 2.42; 95% CI 1.37-4.25), respectively.

CONCLUSION

Changing from written to verbal consent is associated with significant improvement in the timeliness of tPA administration in acute ischemic stroke.

摘要

目的

组织型纤溶酶原激活剂(tPA)溶栓治疗的疗效高度依赖时间。尽管临床指南不建议进行书面知情同意,因为这可能导致治疗延误,但地方政策可以取代并要求进行书面知情同意。2014 年至 2017 年,新加坡的五家公立医院中有三家在不同时间点从书面同意改为口头同意。我们旨在研究关于知情同意的医院政策变化与门到针(DTN)时间的关联。

材料和方法

使用来自新加坡中风登记处和当地实践调查的数据,我们分析了 2014 年 7 月至 2017 年 12 月期间所有公立医院中接受 tPA 治疗的 915 名急性缺血性中风患者的患者水平 DTN 时间。在调整临床特征、医院内聚类和时间趋势后,检查政策变化前后患者的 DTN 时间。

结果

政策变化前后患者特征和中风严重程度相似。总体而言,DTN 时间中位数从政策变化前的 68 分钟减少到 53 分钟。在风险调整后,从书面同意改为口头同意与 DTN 时间减少 5.6 分钟相关(95%CI 1.1-10.0)。政策变化后,DTN≤60 分钟和≤45 分钟的患者比例从 35.6%增加到 66.1%(调整后的 OR 1.75;95%CI 1.12-2.74)和 9.3%增加到 36.0%(调整后的 OR 2.42;95%CI 1.37-4.25)。

结论

从书面同意改为口头同意与急性缺血性中风中 tPA 给药及时性的显著改善相关。

相似文献

1
Changes in Informed Consent Policy and Treatment Delays in Stroke Thrombolysis.知情同意政策的变化与卒中溶栓治疗的延误。
J Stroke Cerebrovasc Dis. 2021 Mar;30(3):105551. doi: 10.1016/j.jstrokecerebrovasdis.2020.105551. Epub 2020 Dec 19.
2
Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.质量改进举措实施前后急性缺血性脑卒中患者组织型纤溶酶原激活剂给药的门到针时间与临床结局。
JAMA. 2014;311(16):1632-40. doi: 10.1001/jama.2014.3203.
3
Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.患者急性缺血性脑卒中溶栓时间的医院差异:从门到影像时间和影像到针时间的作用。
JAMA Neurol. 2014 Sep;71(9):1155-61. doi: 10.1001/jamaneurol.2014.1528.
4
Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.在临床实践中使用策略改善急性缺血性卒中患者使用组织型纤溶酶原激活剂的门针时间:“目标:卒中”研究结果
Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1). doi: 10.1161/CIRCOUTCOMES.116.003227.
5
A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017.2008年至2017年急性缺血性中风患者从入院到开始溶栓治疗时间的十年改善情况
Circ Cardiovasc Qual Outcomes. 2018 Dec;11(12):e004981. doi: 10.1161/CIRCOUTCOMES.118.004981.
6
Timely Reperfusion in Stroke and Myocardial Infarction Is Not Correlated: An Opportunity for Better Coordination of Acute Care.中风与心肌梗死的及时再灌注不存在相关性:改善急性护理协调的契机。
Circ Cardiovasc Qual Outcomes. 2017 Mar;10(3). doi: 10.1161/CIRCOUTCOMES.116.003148.
7
Collaborative Interventions Reduce Time-to-Thrombolysis for Acute Ischemic Stroke in a Public Safety Net Hospital.协作干预措施缩短了公共安全网医院急性缺血性卒中的溶栓时间。
J Stroke Cerebrovasc Dis. 2017 Jul;26(7):1500-1505. doi: 10.1016/j.jstrokecerebrovasdis.2017.03.004. Epub 2017 Apr 7.
8
Regional Learning Collaboratives Produce Rapid and Sustainable Improvements in Stroke Thrombolysis Times.区域学习协作组在卒中溶栓时间方面实现了快速且可持续的改善。
Circ Cardiovasc Qual Outcomes. 2016 Sep;9(5):585-92. doi: 10.1161/CIRCOUTCOMES.116.003222. Epub 2016 Sep 13.
9
Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke.医院用于提高急性缺血性脑卒中组织型纤溶酶原激活剂治疗速度的策略。
Stroke. 2014 May;45(5):1387-95. doi: 10.1161/STROKEAHA.113.003898. Epub 2014 Apr 8.
10
Door to needle time trends after transition to tenecteplase: A Multicenter Texas stroke registry.替奈普酶转换后门到针时间趋势:德克萨斯州多中心卒中登记研究。
J Stroke Cerebrovasc Dis. 2024 Aug;33(8):107774. doi: 10.1016/j.jstrokecerebrovasdis.2024.107774. Epub 2024 May 23.

引用本文的文献

1
Author Response: Factors Requiring Improvement for Timely and Effective Treatment of Acute Stroke.作者回复:急性卒中及时有效治疗所需改进的因素。
Indian J Crit Care Med. 2023 Dec;27(12):949-950. doi: 10.5005/jp-journals-10071-24591.
2
Decision-making psychological state and characteristic of proxies of thrombolytic patients: a pilot study.溶栓患者代理人的决策心理状态和特征:一项初步研究。
Sci Rep. 2022 Jun 20;12(1):10345. doi: 10.1038/s41598-022-14124-x.